Rat-Specific Features: While direct sequence data for recombinant rat Atp5g2 is limited, it shares ~57% identity with human and mouse orthologs .
Key Domains: Includes a mitochondrial targeting sequence (MTS) for import into mitochondria .
Recombinant Atp5g2 is typically produced in bacterial systems (e.g., E. coli) due to cost-effectiveness and scalability. Key steps include:
Cloning: Insertion of the Atp5g2 gene into expression vectors with affinity tags (e.g., His-tag, GST-tag) .
Induction: Growth in optimized media (e.g., LB broth) and induction with IPTG or similar agents.
Purification: Nickel- or glutathione-affinity chromatography for tag-based separation .
Proper Folding: Mitochondrial membrane proteins often face challenges in bacterial expression due to hydrophobic regions .
Stability: Repeated freeze-thaw cycles degrade activity; aliquoting recommended .
Atp5g2 is part of the F₀ complex c-ring, which drives proton transport. Studies in rat models highlight its importance:
Genetic Complementation: Transgenic expression of ATP synthase subunits in rats with Tmem70 deficiency restored mitochondrial function, confirming Atp5g2’s role in proton channel assembly .
Proton-Transport Efficiency: Mutations in Atp5g2 reduce ATP synthase activity, impairing oxidative phosphorylation .
| Application | Method | Outcome |
|---|---|---|
| Antibody Blocking | Recombinant protein as control fragment | Validation of antibody specificity |
| Mitochondrial Targeting | PTD-mediated delivery (e.g., TAT-fusions) | Enhanced mitochondrial uptake in vitro |
| Disease Modeling | Studies in ceroid lipofuscinosis (Batten disease) | Link between ATP synthase dysfunction and lipid accumulation |
ATP5G2 is one of three nuclear genes (along with ATP5G1 and ATP5G3) that encode the c-subunit (subunit 9) of the mitochondrial ATP synthase Fo complex . All three genes encode identical mature proteins but with different mitochondrial-targeting sequences that are removed during import into the organelle . The c-subunit forms a ring structure in the mitochondrial inner membrane that is essential for proton translocation, driving ATP synthesis by the F1 catalytic portion. The mature protein is highly hydrophobic and contains approximately 75 amino acids that form two transmembrane helices.
Recombinant Rat ATP5G2 can be expressed in mammalian cell systems to ensure proper folding and post-translational modifications . The protein is typically tagged (e.g., with a His-tag) to facilitate purification . According to standard protocols, the purified protein should be maintained at >80% purity with endotoxin levels below 1.0 EU per μg as determined by the LAL method . For storage, the protein can be maintained in PBS buffer at +4°C for short-term use or at -20°C to -80°C for long-term storage . When designing experiments, researchers should consider that custom production typically requires 5-9 weeks lead time .
While ATP5G1, ATP5G2, and ATP5G3 encode identical mature c-subunits, their expression patterns show tissue-specific and condition-dependent regulation. In clear cell renal cell carcinoma (ccRCC), all three genes are significantly downregulated compared to normal renal tissue, with ATP5G1 showing the most dramatic reduction (fold changes of -8.09/-5.88 in screening/validation cohorts), followed by ATP5G3 (-3.10/-2.37) and ATP5G2 (-2.69/-2.11) . This differential regulation suggests distinct transcriptional control mechanisms for each gene, potentially allowing for context-specific modulation of ATP synthase activity under various physiological and pathological conditions.
To differentiate the specific contributions of ATP5G2 from its paralogs, researchers can employ several methodological approaches:
Gene-specific knockdown using siRNA or shRNA targeting the unique 5'-UTR or mitochondrial targeting sequence regions of ATP5G2 mRNA
CRISPR-Cas9 gene editing targeting exon IV of ATP5G2, as demonstrated in research creating the HAP1-A12 cell line
Quantitative RT-PCR with primers specific to unique regions of each gene to assess their relative expression levels across tissues or experimental conditions
Protein import studies using constructs containing the ATP5G2 mitochondrial targeting sequence fused to reporter proteins
When designing these experiments, it's crucial to include appropriate controls and validation steps, as the functional redundancy between these three genes may complicate the interpretation of results when only one gene is manipulated.
Several assays can be employed to evaluate ATP synthase function after modifying ATP5G2 expression:
The 9-amino-6-chloro-2-methoxyacridine (ACMA) assay measures ATP synthase enzymatic rate by monitoring proton translocation in submitochondrial vesicles (SMVs)
Mitochondrial membrane potential can be assessed using fluorescent dyes like tetramethyl rhodamine methyl ester (TMRM)
Oxygen consumption rates can be measured using substrates like glutamate/malate and succinate to confirm respiratory complex activity
Native gel electrophoresis can analyze the oligomeric state of ATP synthase complexes, providing insights into assembly and stability
Direct ATP production measurement using luminescent assays to quantify functional output
Each approach provides different insights into ATP synthase function, and combining multiple methods offers a more comprehensive understanding of how ATP5G2 manipulation affects mitochondrial bioenergetics.
Recent research has challenged the hypothesis that the c-subunit forms the mitochondrial permeability transition pore (PTP). To investigate this relationship, researchers can:
Generate cell lines with disrupted ATP5G genes (individually or in combination) as demonstrated with the HAP1-A12 cell line, which lacks all three c-subunit genes yet preserves PTP properties
Measure calcium retention capacity of mitochondria before PTP opening
Test cyclosporin A sensitivity to assess classical PTP involvement
Perform mitochondrial swelling assays in response to calcium or other PTP inducers
Use co-immunoprecipitation or proximity labeling techniques to identify proteins that interact with ATP5G2
Research has shown that mitochondria in HAP1-A12 cells assemble a vestigial ATP synthase with intact F1-catalytic and peripheral stalk domains plus supernumerary subunits e, f, and g, but lacking membrane subunits ATP6 and ATP8 . This suggests that none of the membrane subunits directly involved in proton translocation (including the c-subunit) forms the PTP .
ATP5G2 expression is significantly downregulated in clear cell renal cell carcinoma (ccRCC), as shown in the following comparative data:
| Gene | Screening Cohort Fold Change | Validation Cohort Fold Change |
|---|---|---|
| ATP5G1 | -8.09 | -5.88 |
| ATP5G2 | -2.69 | -2.11 |
| ATP5G3 | -3.10 | -2.37 |
When studying ATP5G2 in cancer contexts, researchers should:
Compare expression between matched tumor and normal tissue samples
Validate findings in independent cohorts
Correlate expression levels with clinical parameters including tumor stage, grade, and patient outcomes
Investigate the functional consequences of ATP5G2 downregulation on mitochondrial metabolism in cancer cells
Research has implicated ATP synthase c-subunit function in Fragile X syndrome (FXS), a neurodevelopmental disorder caused by loss of Fragile X mental retardation protein (FMRP) . Key findings include:
FXS neurons exhibit an ATP synthase "leak" that affects cellular metabolism
Closure of this leak channel by manipulation of c-subunit levels normalizes stimulus-induced and constitutive mRNA translation rates
This normalization decreases lactate and key glycolytic/TCA cycle enzyme levels and triggers synapse maturation
In wild-type neurons, FMRP regulates leak closure through stimulus-dependent ATP synthase β subunit translation, which increases the ratio of ATP synthase enzyme to its c-subunit
In FXS, the inability to close this developmental c-subunit leak prevents stimulus-dependent synaptic maturation
When investigating ATP5G2 in neurological disorders, researchers should consider the distinct roles of mitochondrial bioenergetics in different neural cell types and brain regions, as well as the potential for compensatory mechanisms involving ATP5G1 and ATP5G3.
When investigating ATP5G2 in disease models, researchers should consider these methodological approaches:
Conditional knockout or knockdown systems that allow tissue-specific and temporally controlled manipulation of ATP5G2 expression
CRISPR-Cas9 gene editing to introduce disease-associated mutations or disrupt the gene entirely
Disease-specific phenotyping protocols:
For cancer models: tumor growth, metabolism, and survival assessment
For neurological disorders: electrophysiology, synaptic analysis, and behavioral testing
For metabolic diseases: glucose tolerance, insulin sensitivity, and energy expenditure measurements
Multi-omics approaches combining proteomics, metabolomics, and transcriptomics to comprehensively characterize molecular changes
Pharmacological interventions targeting ATP synthase function to assess potential therapeutic applications
When designing these studies, researchers should account for the functional redundancy between ATP5G1, ATP5G2, and ATP5G3, which may require simultaneous manipulation of multiple genes to observe clear phenotypic effects.
The c-subunit encoded by ATP5G2 forms a critical ring structure in the Fo portion of ATP synthase that interacts with other membrane components. Research using cells with disrupted c-subunit genes has provided valuable insights:
The c-ring is necessary for stable incorporation of membrane subunits ATP6 and ATP8 into the complex
Without c-subunits, a vestigial ATP synthase forms containing F1-catalytic and peripheral stalk domains plus supernumerary subunits e, f, and g, but lacking ATP6 and ATP8
The oligomeric state of ATP synthase depends on the presence of the c-ring, as demonstrated by native gel electrophoresis comparing wild-type versus c-subunit-deficient cells
The dimerization interface likely relies on subunits e and g and may also involve supernumerary subunits f, DAPIT, and 6.8PL
Regulation of ATP5G2 expression can be studied through multiple methodological approaches:
Promoter analysis using reporter constructs to identify regulatory elements controlling transcription
Chromatin immunoprecipitation (ChIP) to identify transcription factors binding to the ATP5G2 promoter
Epigenetic profiling through bisulfite sequencing and ChIP-seq to characterize DNA methylation and histone modifications
miRNA binding site analysis and validation using miRNA mimics or inhibitors
From existing research, we know that:
ATP5G2 expression is significantly downregulated in clear cell renal cell carcinoma
In Fragile X syndrome, ATP5G2 c-subunit mRNA is elevated, but its translation may not be regulated by FMRP (unlike ATP synthase β subunit)
These findings suggest complex regulatory mechanisms that may be context-dependent and involve both transcriptional and post-transcriptional controls. Studies should incorporate multiple cell types and disease states to fully characterize these regulatory pathways.
Studying post-translational modifications (PTMs) of the c-subunit requires specialized approaches:
Mass spectrometry-based methods:
Enrichment strategies for specific PTMs (phosphorylation, acetylation, etc.)
Targeted proteomics to identify and quantify modified peptides
Comparison of PTM profiles under different physiological conditions
Site-directed mutagenesis:
Generate mutants where potential modification sites are altered
Express these mutants in cells lacking endogenous c-subunits
Assess functional consequences on ATP synthase assembly and activity
Functional correlation studies:
Link PTM changes to alterations in ATP synthase activity
Compare PTM patterns across different tissues and disease states
Investigate enzymes responsible for specific modifications
Researchers should be aware that studying PTMs of the mature c-subunit presents technical challenges due to its small size and high hydrophobicity. Additionally, since ATP5G1, ATP5G2, and ATP5G3 encode identical mature proteins, distinguishing modifications specific to the ATP5G2-encoded protein requires careful experimental design or the use of cells where ATP5G1 and ATP5G3 have been knocked out.
Several complementary structural biology techniques can provide insights into c-subunit structure-function relationships:
Cryo-electron microscopy of intact ATP synthase complexes to visualize the c-ring in its native context
X-ray crystallography of purified c-rings to determine high-resolution structural details
NMR spectroscopy for studying dynamic aspects of c-subunit structure in membrane environments
Molecular dynamics simulations to predict conformational changes during proton translocation
Site-directed mutagenesis of key residues combined with functional assays to correlate structure with function
Recent advances in structural biology have improved our understanding of how the c-subunit contributes to proton translocation and ATP synthesis. Researchers should consider that extraction methods can affect the oligomeric state of ATP synthase complexes, as demonstrated by the variable results obtained with different digitonin concentrations used for extraction from 143B ρ0 cells .
Distinguishing direct effects from compensatory mechanisms requires carefully designed experimental approaches:
Gene-specific knockdown with phenotype rescue:
Deplete ATP5G2 using targeted siRNA
Attempt rescue with an siRNA-resistant ATP5G2 construct
Compare with rescue using ATP5G1 or ATP5G3 overexpression
Time-course experiments:
Use inducible knockout/knockdown systems
Monitor immediate versus long-term effects
Distinguish primary effects from secondary compensatory responses
Combinatorial genetic manipulation:
Tissue-specific analysis to identify context-dependent roles and compensation patterns
These approaches help delineate the specific contribution of ATP5G2 to mitochondrial function while accounting for the functional redundancy between the three c-subunit genes.
Several high-throughput approaches can accelerate research on ATP5G2 function:
CRISPR-based functional genomics:
Genome-wide CRISPR screens in ATP5G2-modified backgrounds
Identification of synthetic lethal interactions
Discovery of compensatory pathways
Multi-omics integration:
RNA-seq to detect transcriptional responses to ATP5G2 manipulation
Proteomics to identify changes in protein abundance and modifications
Metabolomics focused on energy metabolism intermediates
Network analysis to identify coordinated responses
High-content imaging:
Automated microscopy with multiple fluorescent markers
Simultaneous tracking of mitochondrial morphology, membrane potential, and ROS production
Correlation of subcellular phenotypes with ATP5G2 expression levels
Drug screening:
Identification of compounds that modulate ATP synthase function
Testing of combinations with ATP5G2 manipulation
Discovery of context-specific vulnerabilities
These approaches enable systematic characterization of ATP5G2 function across different cellular contexts, potentially revealing unexpected roles beyond its canonical function in ATP synthesis.
Recent research has significantly revised our understanding of the relationship between c-subunits and the mitochondrial permeability transition pore (PTP):
Researchers generated a clonal cell line (HAP1-A12) with disrupted ATP5G1, ATP5G2, and ATP5G3 genes, eliminating all c-subunit production . Key findings include:
This research significantly advances our understanding of mitochondrial biology by excluding c-subunits as direct PTP components, redirecting attention to other potential structural elements of this enigmatic channel.
Recent research has revealed interesting connections between ATP synthase c-subunits and neurological conditions, particularly Fragile X syndrome:
In neurons lacking FMRP (Fragile X mental retardation protein), there appears to be a persistent leak in ATP synthase that affects cellular metabolism
Closure of this leak channel through c-subunit manipulation normalizes multiple cellular phenotypes:
In wild-type neurons, FMRP regulates leak closure through stimulus-dependent ATP synthase β subunit translation, increasing the ratio of ATP synthase enzyme to its c-subunit
This mechanism enhances ATP production efficiency and promotes synaptic growth in normal conditions but fails in Fragile X syndrome
These findings suggest potential therapeutic approaches targeting ATP synthase function in neurological disorders, including pharmacological agents that modulate ATP synthase leak or interventions targeting downstream metabolic pathways affected by altered mitochondrial function.
Computational approaches are increasingly valuable for studying ATP5G2 structure, function, and interactions:
Molecular dynamics simulations:
Model the behavior of the c-ring in lipid bilayers
Predict conformational changes during proton translocation
Assess the impact of mutations on structure and function
Systems biology approaches:
Integrate ATP5G2 into genome-scale metabolic models
Predict systemic effects of ATP5G2 alterations
Model impact on mitochondrial energy production pathways
Machine learning applications:
Predict functional consequences of ATP5G2 variants
Identify patterns in gene expression data
Discover potential regulatory mechanisms
Network analysis:
Map protein-protein interaction networks involving ATP5G2
Identify hub proteins that coordinate with ATP5G2 function
Predict synthetic lethal interactions
These computational approaches complement experimental studies by generating testable hypotheses, guiding experimental design, and providing mechanistic insights that may be difficult to obtain through experimental methods alone.